Status:
COMPLETED
One-stage Bone Lengthening in the Management of Brachymetatarsia
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Brachymetatarsia
Eligibility:
All Genders
18+ years
Brief Summary
Brachymetatarsia is a shortening in length of a metatarsal exceeding 5mm. This congenital anomaly most often affecting women and the second metatarsal is associated with frequent aesthetic disorders l...
Eligibility Criteria
Inclusion
- Patients operated on for a one-time lengthening for isolated brachymetatarsia
- Major patients
Exclusion
- Patient refusing to participate in research
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04287127
Start Date
January 1 2019
End Date
January 1 2020
Last Update
March 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295